BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

15036

0

INFINIUM

img img img img
No Data Available

INFINIUM PHARMACHEM LTD performance

Today’s low

Today’s high

₹ 226.00 ₹ 240.50
₹ 227.00

52 week low

52 week high

₹ 213.90 ₹ 337.00
₹ 227.00

Open Price

₹ 232.00

Prev. Close

₹ 233.00

Volume (Shares)

3000.00

Total traded value

₹ 6.81

Upper Circuit

₹ 256.30

Lower Circuit

₹ 209.70

info

INFINIUM PHARMACHEM LTD Share Price Update

As of the latest trading session, INFINIUM PHARMACHEM LTD share price is currently at ₹ 227, which is down by ₹ -6.00 from its previous closing. Today, the stock has fluctuated between ₹ 226.00 and ₹ 240.50. Over the past year, INFINIUM PHARMACHEM LTD has achieved a return of -24.65 %. In the last month alone, the return has been -10.38 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

INFINIUM PHARMACHEM LTD fundamentals


  • Market cap (Cr)

    353.70

  • P/E Ratio (TTM)

    42.91

  • Beta

    1.25

  • Book Value / share

    67.83

  • Return on equity

    10.36%

  • EPS (TTM)

    5.43

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

INFINIUM PHARMACHEM LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 136.92
Operating Expense 127.44
Net Profit 8.47
Net Profit Margin (%) 6.18
Earnings Per Share (EPS) 5.82
EBITDA 17.29
Effective Tax Rate (%) 27.04
Particulars MAR 2024 (Values in Cr)
Revenue 122.36
Operating Expense 109.13
Net Profit 11.09
Net Profit Margin (%) 9.06
Earnings Per Share (EPS) 7.97
EBITDA 19.05
Effective Tax Rate (%) 25.37
Particulars MAR 2023 (Values in Cr)
Revenue 101.31
Operating Expense 90.39
Net Profit 9.15
Net Profit Margin (%) 9.03
Earnings Per Share (EPS) 18.00
EBITDA 16.55
Effective Tax Rate (%) 25.44
Particulars MAR 2022 (Values in Cr)
Revenue 74.04
Operating Expense 67.56
Net Profit 5.50
Net Profit Margin (%) 7.42
Earnings Per Share (EPS) 54.13
EBITDA 9.65
Effective Tax Rate (%) 25.64
Particulars MAR 2021 (Values in Cr)
Revenue 54.56
Operating Expense 51.41
Net Profit 2.72
Net Profit Margin (%) 4.98
Earnings Per Share (EPS) 26.75
EBITDA 5.53
Effective Tax Rate (%) 27.65
Particulars MAR 2025 (Values in Cr)
Book Value / Share 70.25
ROE % 11.58
ROCE % 15.64
Total Debt to Total Equity 0.38
EBITDA Margin 13.73
Particulars MAR 2024 (Values in Cr)
Book Value / Share 42.24
ROE % 28.28
ROCE % 28.57
Total Debt to Total Equity 0.50
EBITDA Margin 14.79
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.39
ROE % 55.06
ROCE % 36.74
Total Debt to Total Equity 1.45
EBITDA Margin 15.23
Particulars MAR 2022 (Values in Cr)
Book Value / Share 128.88
ROE % 66.43
ROCE % 38.89
Total Debt to Total Equity 1.64
EBITDA Margin 11.06
Particulars MAR 2021 (Values in Cr)
Book Value / Share 69.09
ROE % 48.40
ROCE % 32.17
Total Debt to Total Equity 1.72
EBITDA Margin 7.91
Particulars MAR 2025 (Values in Cr)
Book Value / Share 67.84
ROE % 10.36
ROCE % 13.22
Total Debt to Total Equity 0.33
EBITDA Margin 12.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 41.50
ROE % 27.91
ROCE % 29.32
Total Debt to Total Equity 0.43
EBITDA Margin 15.57
Particulars MAR 2023 (Values in Cr)
Book Value / Share 42.69
ROE % 53.43
ROCE % 36.86
Total Debt to Total Equity 1.42
EBITDA Margin 16.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 123.45
ROE % 56.12
ROCE % 34.43
Total Debt to Total Equity 1.69
EBITDA Margin 13.03
Particulars MAR 2021 (Values in Cr)
Book Value / Share 69.31
ROE % 47.85
ROCE % 31.75
Total Debt to Total Equity 1.70
EBITDA Margin 10.14
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 34.84
Total Assets 198.38
Total Liabilities 198.38
Total Equity 124.79
Share Outstanding 15583120
Price to Book Ratio 3.57
Return on Assets (%) 4.10
Return on Capital (%) 4.61
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 11.91
Total Assets 85.45
Total Liabilities 85.45
Total Equity 60.23
Share Outstanding 13916120
Price to Book Ratio 5.52
Return on Assets (%) 13.22
Return on Capital (%) 15.81
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.98
Total Assets 70.61
Total Liabilities 70.61
Total Equity 23.78
Share Outstanding 5083060
Price to Book Ratio 0.00
Return on Assets (%) 13.43
Return on Capital (%) 17.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.45
Total Assets 58.99
Total Liabilities 58.99
Total Equity 13.92
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 10.34
Return on Capital (%) 16.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.98
Total Assets 34.18
Total Liabilities 34.18
Total Equity 7.21
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 7.97
Return on Capital (%) 15.37
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 33.28
Total Assets 166.12
Total Liabilities 166.12
Total Equity 105.71
Share Outstanding 15583120
Price to Book Ratio 3.57
Return on Assets (%) 5.09
Return on Capital (%) 5.61
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.17
Total Assets 77.74
Total Liabilities 77.74
Total Equity 57.75
Share Outstanding 13916120
Price to Book Ratio 5.52
Return on Assets (%) 14.26
Return on Capital (%) 16.89
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.31
Total Assets 60.41
Total Liabilities 60.41
Total Equity 21.69
Share Outstanding 5083060
Price to Book Ratio 0.00
Return on Assets (%) 15.14
Return on Capital (%) 19.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.54
Total Assets 49.05
Total Liabilities 49.05
Total Equity 12.54
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 11.21
Return on Capital (%) 15.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 30.80
Total Liabilities 30.80
Total Equity 7.04
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 8.82
Return on Capital (%) 15.49
Particulars MAR 2025 (Values in Cr)
Net Income 11.56
Cash from Operations -25.26
Cash from Investing -27.24
Cash from Financing 79.29
Net change in Cash 22.92
Free Cash Flow -20.00
Particulars MAR 2024 (Values in Cr)
Net Income 15.21
Cash from Operations 8.58
Cash from Investing -3.79
Cash from Financing 4.80
Net change in Cash 5.93
Free Cash Flow 12.10
Particulars MAR 2023 (Values in Cr)
Net Income 12.95
Cash from Operations 11.70
Cash from Investing -4.95
Cash from Financing -3.10
Net change in Cash 0.52
Free Cash Flow 19.17
Particulars MAR 2022 (Values in Cr)
Net Income 8.63
Cash from Operations 13.75
Cash from Investing -6.63
Cash from Financing -1.70
Net change in Cash 3.46
Free Cash Flow 18.47
Particulars MAR 2021 (Values in Cr)
Net Income 3.76
Cash from Operations 8.33
Cash from Investing -4.99
Cash from Financing -1.15
Net change in Cash 1.13
Free Cash Flow 13.41
Particulars MAR 2025 (Values in Cr)
Net Income 11.60
Cash from Operations -22.69
Cash from Investing -23.14
Cash from Financing 74.20
Net change in Cash 25.11
Free Cash Flow -18.28
Particulars MAR 2024 (Values in Cr)
Net Income 14.86
Cash from Operations 6.78
Cash from Investing -3.29
Cash from Financing 5.03
Net change in Cash 4.86
Free Cash Flow 10.09
Particulars MAR 2023 (Values in Cr)
Net Income 12.26
Cash from Operations 10.44
Cash from Investing -2.58
Cash from Financing -2.99
Net change in Cash 1.77
Free Cash Flow 15.09
Particulars MAR 2022 (Values in Cr)
Net Income 7.40
Cash from Operations 11.04
Cash from Investing -7.17
Cash from Financing -1.65
Net change in Cash 0.30
Free Cash Flow 15.74
Particulars MAR 2021 (Values in Cr)
Net Income 3.75
Cash from Operations 7.86
Cash from Investing -4.59
Cash from Financing -1.12
Net change in Cash 1.10
Free Cash Flow 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.86 13.17 1.39 205.84 25.97 / 68.00
BLISS GVS PHARMA LTD 150.45 14.52 1.40 1591.60 105.05 / 190.65
CIPLA LTD 1489.15 22.11 3.65 120289.25 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 300.55 7.90 2.26 884.55 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.86 21.84 3.74 205.84 25.97 / 68.00
AMRUTAJAN HEALTH LTD 651.80 33.24 5.50 1884.39 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9014.05 97.48 28.20 22535.13 6301.00 / 10653.05
BLISS GVS PHARMA LTD 150.45 20.30 1.44 1591.60 105.05 / 190.65

INFINIUM PHARMACHEM LTD shareholding pattern

Holding

40.08%
59.91%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

INFINIUM PHARMACHEM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
227.00 -2.57 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 236.10
  • 26 Days 243.50
  • 10 Days 238.10
  • 50 Days 248.40
  • 12 Days 238.80
  • 100 Days 256.10
  • 20 Days 241.80
  • 200 Days 262.40
235.33 PIVOT

First Support

230.67

First Resistance

237.67

Second Support

228.33

Second Resistance

242.33

Third Support

223.67

Third Resistance

244.67

RSI

41.20

ADX

14.54

MACD

-4.63

Williams % R

-63.73

Commodity Channel Index (CCI)

-76.29

Date

2025-12-10

Week

2000.00

Same Day

6500.00

Month

3386.00

1 Year

1.26

3 Year

0.49

Over 1 Month

-10.38%

down

Over 1 Year

-24.65%

down

Over 3 Months

-9.07%

down

Over 3 Years

46.63%

down

Over 6 Months

-20.88%

down

Over 5 Years

0.00%

down

INFINIUM PHARMACHEM LTD Corporate Actions

Ex-Date Ex-Bonus Ratio
13 Sep 2023 13 Sep 2023 1:1

INFINIUM PHARMACHEM LTD Share Price

Infinium Pharmachem Limited was originally incorporated as 'Infinium Pharmachem Private Limited' on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted its status into Public Company and the name of Company was changed to 'Infinium Pharmachem Limited' vide fresh Certificate of Incorporation dated August 12, 2022. Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates . The Company has its manufacturing plant at Dist. Anand, Gujarat, since inception.

The Company's manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics, etc. Apart from these, it provides a range of Iodine derivatives in the market, with more than 200 intermediates and over 7 APIs.

Later, in 2019, the Company formed a Joint Venture (JV) with Shanghai Witofly Chemical Co. Ltd., in the name of Shanghai Tajilin Industrial Co. Ltd., in the People's Republic of China. It also formed a Subsidiary Company in the name of Infinium Green Energy Private Limited on June 06, 2022.

The Company came up with a public issue of 18,75,000 Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 25.25 Crore in April, 2023.

In FY2025, Company completed the expansion cum modernization of iodine derivatives manufacturing facility in Anand District of Gujarat. The installed production capacity increased to 1,800 MT per annum during the year. The Company further launched a new product line IOHEXOL (API)' in FY25.

Parent organization Indian Private
NSE symbol INFINIUM
Founded 2003
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Infinium Pharmachem Ltd?

Answer Field

Infinium Pharmachem Ltd share price is for NSE ₹ 227.00 & for BSE ₹ 0.00 as on Dec 11 2025 02:19 PM.

What is the Market Cap of Infinium Pharmachem Ltd Share?

Answer Field

The market cap of Infinium Pharmachem Ltd for NSE ₹ 353.73 & for BSE ₹ 0.00 as on Dec 11 2025 02:19 PM.

What is the 52 Week High and Low of Infinium Pharmachem Ltd?

Answer Field

The 52 Week High and Low of Infinium Pharmachem Ltd for NSE is ₹ 337.00 and ₹ 213.90 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Infinium Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been -24.65%.

What is the P/E Ratio of Infinium Pharmachem Ltd Share?

Answer Field

As on Dec 11 2025 02:19 PM the price-to-earnings (PE) ratio for Infinium Pharmachem Ltd share is 42.91.

What is the PB ratio of Infinium Pharmachem Ltd Share?

Answer Field

As on Dec 11 2025 02:19 PM, the price-to-book (PB) ratio for Infinium Pharmachem Ltd share is 67.83.

How to Buy Infinium Pharmachem Ltd Share?

Answer Field

You can trade in Infinium Pharmachem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Infinium Pharmachem Ltd Share on Bajaj Broking App?

Answer Field

To buy Infinium Pharmachem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Infinium Pharmachem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59